Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

This growth is primarily driven by the rising global cancer incidence, increasing preference for non-invasive diagnostic ...

Tech-savvy parents to be are using IVF and screening embryos to build families in ways that were unimaginable a few short years ago.

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to ...

Across the Bay Area, a growing cohort of founders, investors, and technologists is approaching parenthood in a way that looks ...

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...

The global liquid biopsy market, poised for significant growth, benefits from increased demand for non-invasive cancer ...